Alcon will publish its results for the third quarter of 2025 on November 11, 2025. Analysts expect revenue of around USD 2.63 billion and earnings per share (EPS) of approximately USD 0.76. By comparison, in the third quarter of 2024, revenue stood at about USD 2.4 billion and EPS at USD 0.81. This would represent revenue growth of around 10% year over year, while earnings per share are expected to be slightly below the previous year’s level.
Alcon’s business development remains dynamic, driven by solid demand for premium intraocular lenses and innovative contact lens products. In addition, new product launches and continued investments in research and development are strengthening the company’s competitiveness and creating further growth potential in the coming quarters.
Should Alcon exceed or miss market expectations, significant price movements are possible. This could offer attractive trading opportunities for active investors – particularly through the use of leveraged products.
We look forward to answering all of your questions about our products and how they are traded. Please don't hesitate to get in touch! Phone: 058 800 11 11, email info@leonteq.com or contact us here.